Medx Health Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDXHF research report →
Price Chart
About the company
MedX Health Corp is a medical technology company specializing in both diagnostic tools and therapeutic devices. The firm develops, manufactures, and markets advanced solutions for skin screening and light-based therapy, serving customers across Canada, the United States, and international markets. Its diagnostic portfolio includes SIAscopy, a cutting-edge medical device technology designed to scan skin for early detection of suspicious moles and lesions.
- CEO
- John Gevisser
- IPO
- 2008
- Employees
- 312
- HQ
- Mississauga, ON, CA
Get TickerSpark's AI analysis on MDXHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.20M
- P/E
- -1.85
- Fwd P/E
- 2.30
- PEG
- 0.13
- P/S
- 20.43
- P/B
- -1.09
- EV/EBITDA
- -4.82
- Div Yield
- 0.00%
- Gross Margin
- -8.00%
- Op Margin
- -750.25%
- Net Margin
- -1085.58%
- ROE
- 62.03%
- ROIC
- 212.90%
Latest fiscal year · YoY change
- Revenue
- $472.88K-3.4%
- Gross Profit
- $-88,929-145.8%
- Op Income
- $-4,288,562
- Net Income
- $-6,285,302-72.1%
- EPS
- $-0.02-54.0%
- OCF Growth
- -48.4%
- FCF Growth
- -48.5%
- 52W High
- $0.05
- 52W Low
- $0.01
- 50D MA
- $0.03
- 200D MA
- $0.03
- Beta
- 1.79
- RSI (14)
- 32
- Avg Volume
- 158
No earnings-call transcripts are available for MDXHF yet.
- Free Float
- 65.4%
- Shares Outstanding
- 327.93M
- Float Shares
- 214.49M
Our MDXHF coverage
Recent articles, reports, and earnings notes.
No research on MDXHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDXHF report →MedX Health Appoints Monaderm as a Representative for SkinSecure™ Across Europe for Beauty and Aesthetics Research
businesswire.com · Oct 5
MedX Announces Final Closing of Non-brokered Private Placement
businesswire.com · May 15
MedX Announces Application for Final Extension of Non-Brokered Private Placement
businesswire.com · Apr 15
MedX Announces Application for Extension of Non-Brokered Private Placement
businesswire.com · Mar 16
MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes
businesswire.com · Feb 27
MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes
businesswire.com · Feb 2
MedX Health 2025 YEAR REVIEW
businesswire.com · Dec 15
MedX Announces Final Closing of Non-Brokered Private Placement
businesswire.com · Nov 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.